Vaccine
AstraZeneca resumes COVID-19 vaccine trial after UK green light
AstraZeneca announced on Wednesday it had "voluntarily paused" its trial of the vaccine developed alongside Oxford University after the volunteer developed an...
-
Britain medical regulator reviewing AstraZeneca COVID vaccine trial data
In an email, director of licensing at the Medicines and Healthcare products Regulatory Agency (MHRA) Siu Ping Lam said the regulator is working with the Oxford Vaccine Centre to review the safety data, in line with protocol for the trial.
-
UCT's COVID-19 vaccine participant enrolment wraps up
Researchers said 1,783 participants had so far been enrolled in the randomised control trial nationally.
-
Locally conceived COVID-19 drug trial has started at UCT’s Lung Institute
Pulmonologists say the low cost, widely available antiviral drug has proven to be effective in killing the coronavirus in a laboratory setting.
-
Experts: High ethical standards must be upheld as world races to find COVID cure
This is the word from experts participating in a webinar on vaccine trial ethics on Thursday.
-
WHO urges nations to join global shared vaccine bid
The World Health Organization's director-general Tedros Adhanom Ghebreyesus said that without vaccinating the planet's highest-risk populations simultaneously, it would be impossible to rebuild the global economy.
-
US drug developer Novavax to start mid-stage COVID-19 vaccine experiment in SA
The phase 2B trial study will be conducted on about 2,665 healthy adults and will evaluate the safety and immune response of about 240 medically stable, HIV positive adults.
-
Britain encourages at-risk groups to sign up for COVID-19 vaccine trials
No COVID-19 vaccine candidate has yet been proven effective against the disease, but around 20 are in clinical trials.
-
'Vaccine nationalism': Is it every country for itself?
The deals - including those agreed by the United States, Britain and the European Union with the likes of Pfizer, BioNtech, AstraZeneca and Moderna - are undermining the global drive, experts say.
-
COVID-19 vaccine trial in South Africa: everything you need to know
Professor Madhi anticipates they will be able to provide an answer as to whether this vaccine works and protects against COVID-19 by the end of November.
-
Swiftly waning COVID-19 immunity poses vaccination challenge
That raises big problems for developers of potential COVID-19 vaccines, experts say, and for public health authorities seeking to deploy them to protect populations from future waves of the pandemic.
-
Wits team ready to stop COVID-19 vaccine trial if found to be unsafe
The university will begin trials for the first African COVID-19 vaccine on Wednesday.
-
Race for virus vaccine picks up as Germany, UK start trials
Though there are now around 150 development projects worldwide, the German and British plans are among only five clinical trials on humans which have been approved across the globe.
